Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00872560 | Comparison of 2 NovoFine® Needles on the Reflux of Insulin | PHASE3 | COMPLETED | 60 | — | — | Jan 20, 1998 | Jul 27, 1998 | Aug 7, 2018 | 1 | Italy |
| NCT00871416 | Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles | PHASE3 | COMPLETED | 48 | — | — | Apr 9, 1997 | Jul 18, 1997 | Feb 28, 2017 | 1 | Denmark |
| NCT00343343 | Comparison of NovoFine® Needles (4 mm vs. 6 mm) | PHASE2 | COMPLETED | 62 | — | — | Jun 1, 2006 | Aug 1, 2006 | Feb 8, 2017 | 2 | Denmark |
| Name | Type | Description |
|---|---|---|
| NovoFine® needle 6 mm | DEVICE | - |
| NovoFine® needle 8 mm | DEVICE | - |
| NovoFine® needle 12 mm | DEVICE | - |
| NovoFine® needle 4 mm | DEVICE | - |
Inclusion Criteria: * Children/adolescents with type 1 diabetes mellitus * Usage of NovoPen® 1.5 for at least 3 months * Duration of insulin treatment more than 1 year * Normal weight according to Tanner scales * The means of the last 2 HbA1c measurements taken within the last 6 months must be less...